Accelerating Antimicrobial Discovery with Controllable Deep Generative
  Models and Molecular Dynamics
  De novo therapeutic design is challenged by a vast chemical repertoire and
multiple constraints, e.g., high broad-spectrum potency and low toxicity. We
propose CLaSS (Controlled Latent attribute Space Sampling) - an efficient
computational method for attribute-controlled generation of molecules, which
leverages guidance from classifiers trained on an informative latent space of
molecules modeled using a deep generative autoencoder. We screen the generated
molecules for additional key attributes by using deep learning classifiers in
conjunction with novel features derived from atomistic simulations. The
proposed approach is demonstrated for designing non-toxic antimicrobial
peptides (AMPs) with strong broad-spectrum potency, which are emerging drug
candidates for tackling antibiotic resistance. Synthesis and testing of only
twenty designed sequences identified two novel and minimalist AMPs with high
potency against diverse Gram-positive and Gram-negative pathogens, including
one multidrug-resistant and one antibiotic-resistant K. pneumoniae, via
membrane pore formation. Both antimicrobials exhibit low in vitro and in vivo
toxicity and mitigate the onset of drug resistance. The proposed approach thus
presents a viable path for faster and efficient discovery of potent and
selective broad-spectrum antimicrobials.
